Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 54

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 54
---
 the year ended December 31, 2022. At December 31, 2024, the carrying values and fair values of the Company’s financial assets and liabilities were as follows (in thousands):CarryingValueFair Value Measurements UsingLevel 1Level 2Level 3Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:Financial Assets:  Equity investments$15,877 $— $— $15,877   Convertible notes receivable$11,898 $— $— $11,898 Financial Liabilities: Acquisition-related contingent consideration $20,241 $— $— $20,241 Financial Liabilities Measured at Amortized Cost:Term loan A facility due March 2028$104,211 $— $104,786 $— 2.125% convertible senior notes due 2029 (1)$279,334 $— $247,609 $— 0.750% convertible senior notes due 2025 (2)$201,776 $— $196,678 $— (1) The closing price of the Company’s common stock as reported on the Nasdaq Global Select Market was $18.84 per share on December 31, 2024, compared to a conversion price of $39.56 per share. At December 31, 2024, as the conversion price was above the stock price, the requirements for conversion have not been met.(2) The closing price of the Company’s common stock as reported on the Nasdaq Global Select Market was $18.84 per share on December 31, 2024, compared to a conversion price of $71.78 per share. At December 31, 2024, as the conversion price was above the stock price, the requirements for conversion have not been met. The maximum conversion on the principal that could have been due on the 2025 Notes is 2.8 million shares of the Company’s common stock, which assumes no increase in the conversion rate for certain corporate events.Certain assets and liabilities are measured at fair value on a non-recurring basis, including assets and liabilities acquired in a business combination and long-lived assets, which would be recognized at fair value if deemed impaired or if reclassified as assets held for sale. The fair value in these instances would be determined using Level 3 inputs.Financial Assets and Liabilities Measured